Loading…

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

Saved in:

Bibliographic Details
Published in:	Leukemia 2018-02, Vol.32 (2), p.558-562
Main Authors:	Kerdivel, G, Chesnais, V, Becht, E, Toma, A, Cagnard, N, Dumont, F, Rousseau, A, Fenaux, P, Chevret, S, Chapuis, N, Boeva, V, Fridman, W H, Fontenay, M, Kosmider, O
Format:	Article
Language:	English
Subjects:	631/67/1990/1673 631/67/327 Bone marrow Bone remodeling Cancer Research Care and treatment Critical Care Medicine Development and progression Hematology Immunotherapy Intensive Internal Medicine Lenalidomide letter-to-the-editor Medicine Medicine & Public Health Myelodysplastic syndrome Myelodysplastic syndromes Oncology Patient outcomes Targeted cancer therapy
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!